It is widely accepted that aberrant activation of the Wnt signaling pathway is responsible for the development of precursor lesions of colorectal cancer (CRC).
therapeutic molecular targets need to be sought for the majority of advanced CRCs.
In our previous study, we found that ERKs are constitutively activated by downregulation of DUSP4 through genomic loss, and that this activation is important for cell growth and invasiveness in pancreatic ductal adenocarcinoma. 8 Based on these findings, we hypothesized that a similar mechanism might also play an important role in the growth and invasion of other cancers, including CRC. In the present study, we analyzed CRCs and found evidence of DUSP4 downregulation and hyperphosphorylation of ERKs in the deep region of CRC tissues. In contrast, DUSP4 was strongly expressed and ERK phosphorylation was reduced in the superficial region. Furthermore, in vitro studies suggested that constitutive phosphorylation of ERKs caused by DUSP4 downregulation is important for the growth and invasiveness of CRC and might be a promising therapeutic target.
| MATERIALS AND METHODS

| Cell lines
The CRC cell lines used in this study were selected on the basis of DUSP4 expression data from the Cancer Cell Line Encyclopedia genes in all eight CRC cell lines were obtained from the Cancer Cell Line Encyclopedia. All of them except for HRAS, NRAS, and CDKN2A
are summarized in Table 1 , because these three genes are not mutated in any of the cell lines. edition. 10 Clinicopathological data of all patients are summarized in Table 2 .
| Patients and tissues
T A B L E 1 Genotype data of colorectal cancer cell lines used in this study 
| Lentivirus
Lentivirus encoding DUSP4 cDNA or encoding no cDNAs for transient transduction were generated as described previously. 8 Lentivirus vector expressing constitutively active rat ERK2 mutant was prepared by subcloning of Myc-tagged rat ERK2 (L73P, S151D) 13 cDNA fragment into pLenti7.3/V5-DEST (Thermo Fisher Scientific, Carlsbad, CA, USA). Transduction of CRC cell lines was carried out at an optimized MOI of 5 with Polybrene (Sigma-Aldrich) at a final concentration of 6.0 lg/mL. Forty-eight hours after transduction, the cells were used for the following experiments.
| Cell proliferation assay
Two thousand cells transduced with the lentiviruses or treated with 10 lmol L À1 PD0325901 (LC Laboratories, Woburn, MA, USA) were cultured in 100 lL medium in a 96-well tissue culture plate (Corning, Corning, NY, USA) at 37°C in 5% CO 2 for the indicated duration.
Proliferation was determined using the CellTiter 96 AQueous One Solution Cell Proliferation Assay Kit (Promega, Madison, WI, USA) in accordance with the manufacturer's protocols.
| Invasion assay
Invasiveness of CRC cell line SNU-1033 was determined by the assay using 24-well Transwell culture chambers (Corning, Tewksbury, MA, USA) as described previously, 8 with some modifications. Briefly, the lower and upper surfaces of filters with an 8.0 lm pore size were coated with 1 lg fibronectin (Roche Diagnostics) and 5 lg Matrigel (BD Biosciences, San Jose, CA, USA), respectively. A total of 1 9 10 5 cells in 100 lL culture medium were added to the upper compartment of the chamber, and 600 lL culture medium was added to the lower chamber. To exclude any influence of cell proliferation on invasiveness, 50 ng/mL proliferation inhibitor mitomycin C (Nacalai Tesque, Kyoto, Japan) was applied to the culture medium in both upper and lower chambers. After incubation for 24 hours at 37°C in 5% CO 2 , the filter was fixed with 30% methanol and stained with 0.5% crystal violet in 20% ethanol. The non-invading cells on the upper surface of the filter were then removed using a cotton swab. Subsequently, the filter was excised from the chamber using a scalpel and the number of invaded cells was counted using a microscope in three predetermined fields at a magnification of 9200.
| Immunohistochemistry
For immunohistochemistry, rabbit polyclonal antisera was raised against synthetic peptides corresponding to the amino terminal sequences of human DUSP4 (NH 2 -VHSAPSSLPYLHSP-COOH), and purified by affinity chromatography (Unitech, Chiba, Japan). The specificity of antisera against DUSP4 was confirmed by both immunocytochemistry and Western blot analysis using pancreatic cancer cell lines, PANC-1 stably re-expressing DUSP4 (PANC-1/DUSP4-1) and PANC-1 expressing only the blasticidin resistance gene (PANC-1/cont). 
to the nearest whole number. The sum of the scores for intensity and population was defined as the DUSP4 score in this study. Because the DUSP4 score in normal epithelium adjacent to cancer tissues was 2.58 AE 1.45, DUSP4 scores ≥4 and ≤3 were considered to indicate upregulation and downregulation of DUSP4, respectively.
| Statistical analysis
Statistical analyses in this study were carried out with the JMP statistical software package (SAS Institute, Cary, NC, USA). The effects of re-expression of DUSP4 on cell proliferation and invasiveness was examined using ANOVA and Student's t-test. Comparisons of DUSP4 scores in normal epithelium, superficial region, and deep region were evaluated using Fisher's exact probability test. Differences at P ≤ .05
were considered statistically significant.
| RESULTS
| Downregulation of DUSP4 in SNU-503 and SNU-1003 cells with constitutive activation of ERKs
In our previous study, we found that, under physiologic conditions, DUSP4 is induced by phosphorylated ERKs. It then dephosphorylates ERKs, and is finally downregulated after the ERKs have been inactivated. 8 Therefore, regulation of DUSP4 expression is controlled by a negative feedback loop mechanism mediated by the phosphorylation status of ERKs. Based on these previous data, we first examined the relationship between the expression level of DUSP4 and the phosphorylation level of ERKs in eight CRC cell lines and a normal colonic epithelial cell line, HCoEpiC. As shown in Figure 1A ,B, two of these cell lines, SNU-503 and SNU-1033, showed constitutive activation of ERKs and downregulation of DUSP4. In addition, DUSP4 expression in these two cell lines was increased 2-3.5-fold by treatment with the epigenetic modifiers 5-aza-dC and TSA (Figure 1C) . However, the promoter region of DUSP4 was not hypermethylated in either cell line ( Figure 1D ,E), suggesting that the hypermethylation of the promoter region may not be responsible for this small recovery of epigenetic modifiers. These results suggest that, in CRC cells, DUSP4 downregulation may contribute to ERK activation, similar to the process occurring in pancreatic cancer cells.
| Downregulation of DUSP4 may enhance both proliferation and invasiveness of CRC cells
Next, to confirm whether downregulated DUSP4 in the SNU-503
and SNU-1033 cell lines may cause hyperactivation of ERKs, resulting in a growth advantage and invasiveness, they were transduced with lentivirus encoding DUSP4 and then analyzed for ERK phosphorylation status, cell proliferation, and invasiveness. As shown in Figure 2A , the phosphorylation level of ERKs was clearly reduced in both cell lines following re-expression of DUSP4. Furthermore, the ICHIMANDA ET AL. Figure 3A,B) . Immunohistochemistry using this antibody ( Figure 3C ) revealed that DUSP4 was weakly and focally expressed in the nuclei of normal epithelium adjacent to cancer tissues ( Figure 3D ), but was strongly and diffusely detected in nuclei of CRC cells in the superficial region in 54 of 59 cases (91.5%) ( Figure 3D-F) . In contrast, nuclear expression of DUSP4 was significantly reduced in cells located in the deep region in 46 of 59 cases (78.0%) ( Figure 3D-F) .
Then, we further attempted to determine the phosphorylation levels of ERKs in CRC tissues using immunohistochemistry. However, commercially available antibodies failed to detect phosphorylated ERKs on formalin-fixed, paraffin-embedded sections, as had been reported previously. 14 Therefore, we attempted to compare the phosphorylation status of ERK between the superficial and deep regions of fresh CRC tissues by Western blot analysis. To achieve this, we first excised fresh cancer tissues from the superficial region and deep region of surgically resected CRC tissues, and confirmed microscopically that a sufficient population of cancer cells for Western blot analysis was present in each tissue specimen ( Figure 3G ). Furthermore, using these fresh tissues, we confirmed immunohistochemically that DUSP4 was downregulated in the deep region relative to the superficial region ( Figure 3G ). As shown in Figure 3H , ERKs were relatively hyperphosphorylated in the deep region, whereas DUSP4 expression was obviously downregulated in the deep region. This contrasting pattern of DUSP4 expression and ERK phosphorylation is consistent with our proposal that activation of ERKs in the deep region of CRC may be caused by downregulation of DUSP4.
| DISCUSSION
Somatic mutation of KRAS, NRAS, or BRAF, which is involved in the MAPK signaling pathway, has frequently been found in CRCs. 15, 16 In addition to these mutations, EGFR overexpression detected in a smaller proportion of CRCs is also involved in MAPK signaling, 17 suggesting its importance in the development of CRCs. However, it is still unclear how this pathway is constitutively activated in CRCs.
In this study, we revealed that DUSP4 expression was apparently downregulated in the deep region of CRC tissues compared with the superficial region, and that ERK phosphorylation was conversely increased in the deep region relative to the superficial region. Furthermore, in CRC cell lines in vitro, we found that re-expression of DUSP4 or administration of a MEK inhibitor reduced the degree of cell proliferation and invasiveness. These findings suggest that downregulation of DUSP4 in CRC might promote cell proliferation and invasiveness through activation of ERK.
The molecular mechanisms of DUSP4 downregulation in the deep region of CRC are still unclear. We have recently reported that DUSP4 is downregulated in pancreatic cancer due to genomic loss of 8p, on which the DUSP4 gene is located. 8 In pancreatic cancer, DUSP4 was upregulated in carcinoma in situ without 8p loss through the positive feedback loop of ERK phosphorylation status, but downregulated due to 8p loss in the invasive region of pancreatic cancer.
It has already been reported that 8p loss was detectable in 29% of CRCs. 18 Therefore, it appears that 8p loss in a proportion of CRCs could contribute to downregulation of DUSP4. Another possible mechanism of DUSP4 downregulation could be epigenetic modification. It has been reported that hypermethylation in the promotor region of DUSP4 contributes to its reduced expression in glioblastoma, 9 hepatocellular carcinoma, 19 breast cancer, 20 and lymphoma. 21 In the present study, we were able to detect augmentation of F I G U R E 3 Expression of dual-specificity phosphatase 4 (DUSP4) is upregulated in the superficial region of colorectal cancer (CRC) tissues, but downregulated in the deep region. A, Validation of a novel rabbit anti-DUSP4 polyclonal antibody using PANC-1 cells stably re-expressing DUSP4 (PANC-1/DUSP4-1) and its control clones (PANC-1/cont), which express only the blasticidin resistance gene. Representative images of immunocytochemistry using DAPI and the anti-DUSP4 antibody. The antibody specifically recognized the nucleus of PANC-1/DUSP4-1 but not that of PANC-1/cont. B, Specificity of the antibody was further determined by Western blot analysis using lysates of PANC-1/cont and PANC-1/DUSP4-1. The antibody specifically detected DUSP4 protein in PANC-1/DUSP4-1. C, Representative images of immunohistochemistry for DUSP4 in CRC tissues. The staining intensity in the nucleus of cancer cells was scored as: 0, none; 1, weak; 2, medium; and 3, strong. D, Representative images of immunohistochemistry for DUSP4 in CRC tissues. The insets indicate normal epithelium (1), the superficial region of CRC (2) , and the deep region of CRC (3). Scale bar = 1 mm. E, Immunohistochemical DUSP4 scores for 59 CRC cases. In 42 cases (71.2%, gray boxes), DUSP4 was upregulated and downregulated in the superficial region and deep region, respectively. F, DUSP4 score was significantly higher in the superficial region than in normal epithelium, and was significantly lower in the deep region than in the superficial region. Data shown as mean AE SD. G, H & E staining and immunohistochemistry for DUSP4 in frozen tissues from superficial and deep regions in representative CRC cases. In all sections, the proportion of tumor cells included exceeded 70% of the total. Scale bar = 40 lm. H, Expression levels of DUSP4 protein and phosphorylation levels of ERKs (pERKs) in CRC tissues analyzed by Western blotting. DUSP4 expression was downregulated in the deep region relative to the superficial region, whereas ERKs were hyperactivated in the deep region relative to the superficial region
